Healthscope (HSP) is the second largest private hospital provider, operating pathology businesses and medical centres in Australia and Asia.
HSP has recommended its shareholders accept the $2.7 billion takeover offer from the TPG-Caryle Group private equity consortium.
The offer represents a 16% premium to Friday’s closing price, and is almost 40% higher than HSP’s closing price before it received the first bid.
Encouragingly for HSP, the consortium maintained that it doesn’t plan to break up the group.
HSP Australian share price rocketed 10% yesterday following the announcement.